Publication | Closed Access

Therapy with Nonglycosaminoglycan‐Binding Mutant CCL7: A Novel Strategy to Limit Allograft Inflammation

InflammationNonglycosaminoglycan‐binding Mutant Ccl7Limit Allograft InflammationTransplantationAutoimmune DiseaseInflammatory DiseaseNovel StrategyImmune RegulationImmunologyChronic InflammationAutoimmunityImmunomodulationCell TransplantationImmune SystemMedicineCell BiologyGraft Rejection